Jan 22, 2019 -
Jan 22, 2019 - The Zacks Analyst Blog Highlights: Bank of America, Merck, Netflix, IBM and The Bank of New York Mellon
Jan 21, 2019 - Merck's (MRK) partner, Samsung Bioepis Co. gets FDA approval for Ontruzant, a Herceptin Biosimilar.
Jan 21, 2019 - Top Analyst Reports for Bank of America, Merck & Netflix
Jan 18, 2019 - CDX-6114's success in Phase 1a trials corresponded to a stock price bump. Short-term traders have future CDX-6114 results as upside potential.Partnerships and revenue streams will keep CDXS's stock af
Jan 18, 2019 -
Jan 18, 2019 - Aerie's (AERI) Investigational New Drug Application for AR-1105 for the treatment of macular edema due to retinal vein occlusion is accepted by the FDA. The candidate will now enter clinical studies.
Jan 18, 2019 - The index enjoyed another strong week of gains, increasing over three straight sessions.
Jan 17, 2019 - Roche's (RHHBY) sBLA for the label expansion of Tecentriq in combination with Abraxane for the initial treatment of NSCLC has been accepted by the FDA.
Jan 15, 2019 - Benchmarks ended in the red on Monday as corporate earnings kicked off.